A61K 9/2068
Compounds of unknown constitution
Official title: {Compounds of unknown constitution, e.g. material from plants or animals (oils, fats, waxes, shellac A61K9/2013)}
A61K9/2068 (Compounds of unknown constitution) appears on 230 US grants and 454 published applications in this corpus.
Search patents in A61K- Granted patents
- 230
- Published applications
- 454
- Assignees
- 202
- Inventors
- 633
- Latest grant
- 17 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 5 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 2 |
| 2002 | 4 | 4 |
| 2003 | 4 | 13 |
| 2004 | 4 | 21 |
| 2005 | 2 | 14 |
| 2006 | 6 | 14 |
| 2007 | 5 | 23 |
| 2008 | 2 | 10 |
| 2009 | 1 | 12 |
| 2010 | 8 | 7 |
| 2011 | 8 | 24 |
| 2012 | 8 | 22 |
| 2013 | 8 | 19 |
| 2014 | 19 | 17 |
| 2015 | 10 | 17 |
| 2016 | 7 | 28 |
| 2017 | 10 | 17 |
| 2018 | 9 | 25 |
| 2019 | 16 | 25 |
| 2020 | 16 | 34 |
| 2021 | 13 | 14 |
| 2022 | 14 | 20 |
| 2023 | 10 | 17 |
| 2024 | 13 | 26 |
| 2025 | 15 | 19 |
| 2026 | 1 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Marine organism infused effervescent tablet for producing enhanced suspensions17 Mar 2026US 12,576,036 B1Kuwait University
- Additive composition for formulation capable of stabilizing pore of solid particles and method for production thereof30 Dec 2025US 12,508,230 B2NPK Inc.
- Tablet comprising modoflaner as an active component30 Dec 2025US 12,509,425 B2Virbac
- Pharmaceutical herbo-mineral metallic composition and a process for preparation thereof16 Dec 2025US 12,496,313 B2
- Blend compositions for oral administration as a rapidly dissolving powder and/or suspension18 Nov 2025US 12,472,143 B2Marenda Pharmaceuticals LLC
- Autophagy activator and autophagy activation composition1 Oct 2026US 2026/0294865 A1Maruzen Pharmaceuticals Co., Ltd.
- Methylene blue for use in therapy of hepatitis b and/or hepatitis d infection2 Jul 2026US 2026/0183305 A1
- Central nervous system health supplement25 Jun 2026US 2026/0174728 A1
- Protein Based Soft Chew Tablets28 May 2026US 2026/0144746 A1Fertin Pharma A/S
- Treatment of neuropathic pain in canines23 Apr 2026US 2026/0108484 A1Triviumvet Designated Activity Company
Most cited
By later US patents
- Abuse-proofed dosage form249US 8,114,383 B2Gruenenthal GmbH · 2012
- Abuse-proofed dosage form205US 8,309,060 B2GrüNenthal GmbH · 2012
- Abuse-proof dosage form132US 8,192,722 B2GrüNenthal GmbH · 2012
- Pharmaceutical compositions containing insulin117US 4,579,730 AHadassah Medical Organization · 1986
- Delivery of therapeutic agents73US 5,227,157 ABoard of Regents, The University of Texas System · 1993